Market Authorisation Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Market Authorisation Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Market Authorisation Application Today - Breaking & Trending Today

GenSight Biologics S A : Convening notice – 2023 General Meeting

Published: May 31, 2023

CONVENING OF THE COMBINED GENERAL MEETING ON JUNE 21, 2023 GENSIGHT BIOLOGICS A French Société Anonyme ... | May 31, 2023

Source: marketscreener.com

Related Topics:

United KingdomUnited StatesSaint AntoineFrance GeneralGensight BiologicsCompanies RegistryEuropean Medicines AgencyFrench SociFaubourg Saint AntoineSight BiologicMitochondrial Targeting SequenceLeber Hereditary Optic NeuropathyGensight BiologicMarket Authorisation ApplicationTemporary AuthorizationsEarly Access AuthorisationCombined General MeetingGood Manufacturing PracticesMarketing Authorisation ApplicationHeights CapitalLeber Hereditary Optical NeuropathyTheir RelativesGensight Biologics Sa Stock ExchangePress ReleaseNonyme Sight Fr0013183985

EffRx Pharmaceuticals Signs Exclusive License Agreement With Diurnal for the Registration and Commercialization of Efmody in Switzerland

Published: April 26, 2022

EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced it has recently entered into an exclusive license agreement

Source: finanznachrichten.de

Related Topics:

United KingdomGreat BritainPamela SarediRichard BungayLorenzo BosisioEffrx PharmaceuticalsEuropean UnionEuropean CommissionDiurnal GroupMarket Authorisation ApplicationChief Executive OfficerInterim Chief Executive OfficerProduct CharacteristicsNorthern IrelandUnited Kingdom Headquartered